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ABSTRACT. The most commonly used assay to quantitate the response of peripheral T~cells upon 
stimulation with growth fac:tors is determination of lncorporated (JH]TdR. We compared thls test to three 
other methods: 1. direct countlog of cells with a Coulter type counter as reference assay, 2. a colorlmetric 
assay using the tetrazolium dye 3-[ 4,S-dimethylthiazol-l-yl]-2,5~iphenyl tetrazolium (MTT), whlcb is a 
cbeap and lncreasingly popular non~radioactive method and 3. incorporation of the thymidine analog 5-
bromo-2'-deoxyuridine detection with a monoclonal antibody on cytospins. Primary human PHA-blasts 
from >30 healthy individuals were stimulated with IL-2, IL-4 aod IL-7 and assayed with up to four 
different methods. We discuss the advantages and disadvantages of the assays used and tbe effects of 
differences between cell preparations. We observed no significant variations between indivlduals Jor the 
dose dependence, but the relative emctency of IL4 compared to IL-2 and IL-7 was variable. Thls ·was 
probably due to the slower response observed upon Stimulation wlth tbis factor. 
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INTRODUCTION 
Interleukins (IL) induce numerous effects in 
lymphocytes. Ion movements, protein phosphorylation, 
gene activation, expression of surface markers and 
other events associated with differentiation are 
observed upon Stimulation with appropriate IL's [I -
8]. Most frequently. however. induction of DNA 
synthesis is used to monitor cellular response to IL. 
We have compared the widely used (JH]TdR-assay 
with three other methods that can detect post-
stimulation events in T-cells. Counting of cells by 
means of a Coulter-type counter. incorporation of the 
thymidine analog 5-bromo-2'deoxyuridine (BrdU) 
and detection with a monoclonal antibody on 
cytospins, and cleavage of the tetrazolium dye 3-[4,5-
dimethylthiazol-2-yl]-2.5-diphenyl tetrazolium 
bromide (MTI) by mitochondrial dehydrogenases. 
Human PBMC enriched in T-cells were preactivated 
for 3 d with PHA and subsequently stimulated with 
IL-2. IL-4 or IL-7. All of these factors induce 
proliferation of primed T-cell populations independent 
of other growth factors [9 - 11 ]. but have quite 
different properties otherwise. IL-2 is produced by 
activated T-cells and promotes the proliferation and 
differentiation of T-cells. 8-cells and NK-cells, among 
others (9]. IL-4 is produced by a small percentage of 
activated T-cells (most recently estimated to be 
- 0.1.% for BALB/c mice [ 12]) and by mast cells. as 
first described in the mouse system [ 13]. It was 
described as a differentiation factor for hematopoietic 
stem cells. thymocytes. T-cells and 8-cells. with a 
particular relevance for allergic responses [ 14. 15]. 
IL-7 is produced by stromal cells in bone marrow. 
spieen and thymus. and is best known for its role in 
thymocyte development and hematopoiesis [ 16. 17]. 
We used T-cell preparations from over 30 different 
individuals to compare the maximal proliferation 
induced, the dose-dependence and the relative 
efficiency of the three factors. Our goal was to 
establish the effect of the assay used and of 
differences between cell preparations and individual 
donors on the parameters measured. The results of 
this study allow considerations about the selection of 
an appropriate assay in experimental Situations and 
the minimal numbcr of cell batches that should be 
tested for quantitative estimations. 
MATERIALSAND METHODS 
Cells and growth factors. Lymphocyte concentrates 
from healthy blood donors were obtained from two 
local institutions (Institut für Transfusionsmedizin der 
Universität and Blutbank des Roten Kreuzes). For 
experiments involving repeated testing of samples 
from the same individuum, 30-35 ml of whole blood 
was collected from volunteers within the laboratory. 
In all cases. PBMC were enriched by Ficoll-
centrifugation. washed three tim es in HANKS 's 
buffered salt solution and cultured in RPMI 1640 with 
an addition of I 0% FCS, I 00 U/ml Penicillin and 
98 
l 00 Jlg/ml Streptomycin (all media components from 
Biochrom, Berlin, FRG) at 37°C and 5% C02• Cells 
were prestimulated for 3 days with 9 J.Lg/ml PHA 
(HAIS; Wellcome,.Dartford, England), washed twice 
with RPMI 1640 and incubated with complete 
medium in a 96 weil mikrotitre tray with different 
concentrations of interleukin. 
Human IL-2, IL-4 and IL-7 were expressed in 
Escherichia coli and purified as described [ 18, 19]. 
All three factors were prepared in the laboratory. 
MIT-test. The colorimetric assay for cleavage of the 
dye MTT was performed as described by Mosmann 
[20]. Briefly, 3 d PHA-prestimulated cells were 
suspended in 96 weil roundbottom microtitre trays 
with different concentrations of interleukin at 2.5 x 
105 cells/ml and 100 Jll volume. For the assay, I 0 Jll 
of a 5 mg/ml solution of MTT (Sigma) was added and 
the tray was incubated at 37°C for 4 hours 100 Jll 
isopropanol/0.04 N HCI was added and the dye 
crystals formed were suspended with an 8-tip-pipet. 
The optical density of each weil was determined at 
550 nm against a reference of 630 nm with an 
automatic plate reader (MR 600; Dynatech, 
Billingshurst, England). All experiments were 
performed in duplicate. 
[ 3H]TdR incorporation. Cells were incubated in 
duplicate with or without interleukins at a volume of 
200 Jll and a concentration of 5 x I 05/ml. [3H]TdR 
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(Amersham Buchler, Braunschweig, FRG) was added 
at a concentration of I 00 nM and a specitic activity of 
0.5 JlCi/well. After incubation at 37°C for 4 hours 
cells were harvested with a Cell Harvester (Skatro~ 
Instruments, Lier, Norway) on original Skatron filters, 
which were dried and counted in a radio-TLC-analyser 
(RITA-90; Raytek Scientific Ltd., Sheffield, England). 
BrdU-test. For incorporation and detection of 
5-bromo-2'-deoxyuridine [21, 22], the BrdU/alkaline 
phosphatase-kit (RPM 20) from Amersham Buchler 
· was used according to the manufacturers directions. 
Incubation time with BrdU was varied between 1 hour 
and 4 days. Labelied cells were centrifuged onto 
slides in a cytospin, airdried and the Iabel was 
developed. The cells were counterstained with the 
cytoplasmic dye Eosin Y (Serva). 
Ce// counting and analysis. PHA-prestimulated cells 
were cultured at a volume of 200 Jll and a density of 
1-5 x 105 cells/ml in microtitre trays with IL-2, IL-7 
(both at 50 ng/ml), IL-4 (250 ng/ml) or in medium 
alone. After the incubation times indicated, duplicate 
25-100 Jll aliquots of cells were resuspended in I 0 ml 
PBS and immediately counted in an automatic cell 
counter (CASY 1; Schärfe System, Reutlingen, FRG). 
Analysis of surface markers was performed with a 
Becton Diekinsen (Mountain View, USA) FACScan. 
PE-coupled anti-CD3-antibody was from Becton 
Dickinson, FITC-coupled PHA-E was from E-Y Labs 
(San Mateo, USA). 
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Figure 2. 
Cell numbers counted upon Stimulation 
of PHA-preacti vated cells with 
saturating concentrations of IL-2, IL-7 
(both 50 ng/ml) or IL-4 (250 ng/ml). 
Data given are the average of three 
independent experiments performed in 
duplicate. Control cells were kept in 
medium without stimulus. 
RESULTS AND DISCUSSION 
Pretreatment of cells. Interleukin -dependent 
proliferation of fresh lymphocytes reached a peak 
after 3-4 days of prestimulation with saturating 
concentrations of PHA, regardless of the cytokine 
tested. Flow cytometry showed that 80% (± 6%) of 
cells were CD3+ at that time and >95% bound PHA. 
However, a contribution of contaminating B-cells to 
the observed effects can not be excluded. Throughout 
this study, cells were stimulated with IL after 3 days 
of prestimulation with PHA. The first cell division 
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started 16 hours after addition of IL-2, IL-4 or IL-7, 
but afterwards no synchronization was apparent 
(results not shown) . 
Ce// counting wirh a Coulrer type counter. Actual 
counting of cells is the only method that really 
determines proliferation. i.e. increase in cell number 
by cell division. The method is reliable and 
particularly weil suited if the kinetics of cell 
proliferation have to be measured (figures I a and 2). 
Cell counting is a necessary standard if the validity of 
a proliferation assay is tested (see below). The main 
drawback of the method is the limited number of 
samples that can be processed . 
lncorporaTion of [.1H]TdR. The determination of 
radioactive Iabeiied thymidine is a simple and 
Straightforward assay to measure DNA-synthesis in a 
cell population. It can be seen from figure I b that the 
timing of the assay is important, if factors are 
compared that induce DNA synthesis with different 
kinetics. IL-2 and IL-7 stimulated PHA-blasts in an 
identical fashion, while IL-4 acted slower even at the 
saturating concentration applied [23]. Measuring 
PHJTdR uptake at single time points to compare the 
efficiency of the three growth factors would Iead to 
different results depending on the time of the assay. 
In fact, cell counting showed that IL-4 induced the 
same number of cell divisions in PHA blasts as IL-2 
and IL-7, but with slower kinetics (figure 2). Cells 
might also give variable results if they grow partially 
synchronized. This can be overcome to some extent 
by using Ionger incubation times with the radiocative 
analog. An important advantage of the [ 3H)TdR test 
is that it can usually be applied to different cell types 
without modifications, in contrast to the MTT-
method. 
MTT-assay. Data obtained from MTT-assays 
reasonably weil reflected the ceJI number determined 
by automatic counting (figures Ia and lc). It has been 
claimed that this method can not be applied to 
peripheral lymphocytes, due to some physiologic 
property of these cells, because cells stimulated 3 
days with PHA failed to give a signal in the MTT 
assay, while producing strong PH]TdR-incorporation 
[24]. We have found the same effect, but cell 
counting showed that the number of cells after 3 days 
stimulation with PHA had recovered after a initial 
drop to approximately the same number as at the start 
of the experiment. For this reason no increase in 
MTT-cleavage could be measured, but as the cells 
proliferated vigorously, [JH]TdR was incorporated 
(not shown). We therefore confirm that the MTT-
assay is a good method to estimate cell numbers of 
lymphocytes [25]. For Ionger incubation times (3-4 
days) the MTT-test indicated a lower value than the 
real cell number (figures I a and I c). This may have 
been due to a declining mitochondrial activity [20, 
25]. However, after 3 days, our standard incubation 
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Figure 3. 
Proliferation induced by IL-2, IL-4 or IL-7 in 3d PHA-blasts. 
The maximal signal obtained in the MTT-assay and the 
IL-concentration required for half-maximal stimulation are 
indicated. Values of the IL-dilution necessary for half-maximal 
Stimulation followed a Gaussian distribution with a standard 
deviation of 0. 7 dilution steps for IL-2, I .0 for IL-4 and 1.2 for 
IL-7. The mean concentration required for half-maximal 
response was 780 pg/ml for lL-2, 6.8 ng/ml for IL-4 and 630 
pg/ml for IL-7. The number of data points is !arger here than 
in figure 4, bccause some experiments are included in which 
not all interleukins were tested. 
time, the values were still reasonable. The MTT-
method is much eheaper than any radioactive assay, 
but the compound is cancerogenic. 
BrdU-test. Incubation with BrdU and detection with 
alkaline phosphatase-coupled antibodies stained up to 
50% of the cells for each factor. While this allowed 
visualisation of individual responding cells, the 
method was in our experience not suitable as 
quantitative assay. Cells stained unequally on the 
slides and massive cell death occured after incubation 
with BrdU for one day or more. 
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Relative maximal prolifcrution induced by IL-2, IL-4 or IL-7 
in PHA-blasts from 34 different donors. IL-2-induced 
proliferation is set as I 00% and the relative response obtained 
with the other two interlcukins is indicated . 
Variations between cell preparations. All cell batches 
tested proliferated upon treatment with IL-2, IL-4 and 
IL-7 (figure 3). The concentrations required for half-
maximal stimulation were distributed around a single 
peak with average values of 780 pg/ml (50 pM) for 
IL-2, 6.8 ng/ml (440 pM) for IL-4 and 630 pg/ml 
(37 pM) for IL-7. 
Cell numbers obtained upon stimulation varied at 
least fivefold between different experiments for all 
factors tested. Maxi mal pro I i feration and dose 
requirement were independent of each other (figure 
3). We estimate that about ten cell batches should be 
tested to q uanti tate the maxi mal pro! i ferati ve 
response for a particular interleukin, while fewer 
batches may be sufficient to give a reasonable dose 
response value. 
The proliferation induced by IL-4 was not correlated 
with the response to IL-2 or IL-7 (figure 4 ). IL-2 and 
IL-7 were comparably efficient as proliferation factors 
for PHA-blasts, as reported by others [26, 27]. while 
IL-4 had not only to be applied in tenfold higher 
amounts, but even at saturating concentrations gave 
responses ranging from around 40% to >I 00% of the 
proliferation induced by IL-2 in the same test (figure 
4). The large variations found for IL-4 were due to the 
time of assay (figure 2), which illustrates the 
importance of the protocol used for the determination 
of cellular responses. 
Variations between individual donors. To find out 
how individual variations contribute to differences 
between cell preparations, we have repeatedly tested 
lymphocytes from four individual donors over a 
period of two month. The maximal proliferation 
induced varied by about a factor of two between 
different experiments with cells from the same donor, 
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Figure 5. 
Maximal proli feration induccd by IL-2. IL-4 and IL-7 
determined by MTT-assays in subsequent experiments over a 
period of two months for PHA-blusts from four individual 
donors. IL-2-induced proliferation is set as I 00°..-fJ and thc 
relative responsc obtained with thc othcr two interleukins is 
indicated. Grey column: IL-4. black column: IL-7. 
while the relative response towards the three factors 
when compared to each other was rather reproducible 
(figure 5). In particular, low values for IL-4-induced 
proliferation were found in cells from donor I. while 
high values were determined for donor 4 and 
intermediate ones for donors 2 and 3 (figure 5). The 
main variation between individuals seemed to be in 
the time that IL-4-stimulated cells needed to 
proliferate as vigorously as cells treated with IL-2 or 
IL-7. We conclude that differences during the 
preparations and in the composition of cell batches 
can not account for all variations observec.J. Thereforc, 
cell samples from a number of individuals should be 
used whenever possible. 
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